Compare CADL & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | EGY |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.6M | 561.8M |
| IPO Year | 2021 | 1996 |
| Metric | CADL | EGY |
|---|---|---|
| Price | $9.46 | $5.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $19.00 | $7.30 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $125,000.00 | ★ $359,272,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $29.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $3.36 |
| 52 Week High | $11.36 | $6.72 |
| Indicator | CADL | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 55.42 |
| Support Level | $9.19 | $5.53 |
| Resistance Level | $11.36 | $5.58 |
| Average True Range (ATR) | 0.58 | 0.19 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 24.29 | 68.24 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.